Literature DB >> 1541280

The complete amino acid sequence of the Clostridium botulinum type-E neurotoxin, derived by nucleotide-sequence analysis of the encoding gene.

S M Whelan1, M J Elmore, N J Bodsworth, T Atkinson, N P Minton.   

Abstract

The entire structural gene of the Clostridium botulinum NCTC 11219 type-E neurotoxin (BoNT/E) has been cloned as five overlapping DNA fragments, generated by polymerase chain reaction (PCR). Analysis of triplicate clones of each fragment, derived from three independent PCR, has allowed the derivation of the entire nucleotide sequence of the BoNT/E gene. Translation of the sequence has shown BoNT/E to consist of 1252 amino acids and, as such, represents the smallest BoNT characterised to date. The light chain of the toxin exhibits the highest level of sequence similarity to tetanus toxin (TeTx, 40%). The light chains of BoNT/A and BoNT/D share 33% similarity with BoNT/E, while BoNT/C exhibits 32% similarity. In contrast, the TeTx heavy chain exhibits the lowest degree of similarity (35%) with BoNT/E, with the BoNT heavy chains sharing 46%, 36% and 37%, for neurotoxin types A, C and D, respectively. Comparisons with partial amino acid sequences of the light chain of BoNT/E from C. botulinum strain Beluga and that from the strains Mashike, Iwanai and Otaru, indicate single amino acid differences in each case. Alignment of all characterised neurotoxin sequences (BoNT/A, BoNT/C, BoNT/D, BoNT/E and TeTx) shows them to be composed of highly conserved amino acid domains interspersed with amino acid tracts exhibiting little overall similarity. The most divergent region corresponds to the extreme COOH-terminus of each toxin, which may reflect differences in specificity of binding to neurone acceptor sites.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1541280     DOI: 10.1111/j.1432-1033.1992.tb16679.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  26 in total

1.  Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.

Authors:  T J Smith; J Lou; I N Geren; C M Forsyth; R Tsai; S L Laporte; W H Tepp; M Bradshaw; E A Johnson; L A Smith; J D Marks
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Botulinum neurotoxin types A, B, and E: fragmentations by autoproteolysis and other mechanisms including by O-phenanthroline-dithiothreitol, and association of the dinucleotides NAD(+)/NADH with the heavy chain of the three neurotoxins.

Authors:  Bibhuti R Dasgupta; Babu S Antharavally; William Tepp; Mary L Evenson
Journal:  Protein J       Date:  2005-08       Impact factor: 2.371

3.  Efficacy of a potential trivalent vaccine based on Hc fragments of botulinum toxins A, B, and E produced in a cell-free expression system.

Authors:  R Zichel; A Mimran; A Keren; A Barnea; I Steinberger-Levy; D Marcus; A Turgeman; S Reuveny
Journal:  Clin Vaccine Immunol       Date:  2010-03-31

4.  A Novel Rabbit Spirometry Model of Type E Botulism and Its Use for the Evaluation of Postsymptom Antitoxin Efficacy.

Authors:  Eran Diamant; Avi Pass; Osnat Rosen; Alon Ben David; Amram Torgeman; Ada Barnea; Arnon Tal; Amir Rosner; Ran Zichel
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

5.  Mapping of the antibody-binding regions on botulinum neurotoxin H-chain domain 855-1296 with antitoxin antibodies from three host species.

Authors:  M Z Atassi; B Z Dolimbek; M Hayakari; J L Middlebrook; B Whitney; M Oshima
Journal:  J Protein Chem       Date:  1996-10

6.  Multiplex PCR assay for detection and identification of Clostridium botulinum types A, B, E, and F in food and fecal material.

Authors:  M Lindström; R Keto; A Markkula; M Nevas; S Hielm; H Korkeala
Journal:  Appl Environ Microbiol       Date:  2001-12       Impact factor: 4.792

7.  Physicochemical and immunological characterization of the type E botulinum neurotoxin binding protein purified from Clostridium botulinum.

Authors:  B R Singh; J Foley; C Lafontaine
Journal:  J Protein Chem       Date:  1995-01

8.  Gene probes for identification of the botulinal neurotoxin gene and specific identification of neurotoxin types B, E, and F.

Authors:  K D Campbell; M D Collins; A K East
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

9.  Quantitative real-time reverse transcription-PCR analysis reveals stable and prolonged neurotoxin cluster gene activity in a Clostridium botulinum type E strain at refrigeration temperature.

Authors:  Ying Chen; Hannu Korkeala; Jere Lindén; Miia Lindström
Journal:  Appl Environ Microbiol       Date:  2008-08-15       Impact factor: 4.792

10.  Evidence for a link between specific proteolysis and inhibition of [3H]-noradrenaline release by the light chain of tetanus toxin.

Authors:  D Sanders; E Habermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.